In this episode of the podcast, i walk through Fidson Healthcare Audited FY 24 results.
The key point for me in the numbers are the profit margins on the different drug segments.
Pharma is a sector overlooked on the NGX, but with great potential.
You can find other episodes of the podcast on Spotify and Apple Podcast. Search for greentickertales
Share this post